PS-102
Hematological Malignancies
PreclinicalActive
Key Facts
About Perimeter Systems, Inc.
Developing precision gene therapy delivery platforms for oncology with enhanced tumor targeting and reduced off-target effects.
View full company profileTherapeutic Areas
Other Hematological Malignancies Drugs
| Drug | Company | Phase |
|---|---|---|
| NST-201 (estimated) | Novastage Pharmaceuticals | Preclinical/IND-enabling |
| TYK-201 | TYK Medicines | Preclinical |
| TNB-655 | Tenacia Biotechnology | Preclinical |
| Undisclosed CAR-T Program | OBiO Technology | Phase 1/2 |
| NP-G2-044 | Novita Pharmaceuticals | Phase 2a |
| JaxBio Hematology Cancer Test | JaxBio | Preclinical |
| YZY-002 | YZY Biopharma | Phase 1 |